Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Vaccine

Moderna Hypes 'Important Step' In Flu Shot Results, But Market Disagrees

Moderna stock toppled Friday on mixed results for its flu shot — a rival to experimental vaccines from BioNTech, CureVac and Sanofi.

Investors Business Daily

Valneva Shares Topple As It Hits Ethics Roadblock With Pfizer In Lyme Disease Test

Valneva stock plummeted Friday after Pfizer said it will drop roughly half of the participants enrolled in their Lyme disease vaccine study.

Investors Business Daily

Fit and healthy father diagnosed with stage 4 bowel cancer reveals first warning sign

Geoffrey Seymour discovered blood in his stool just before his 41st birthday, which turned out to be stage four cancer

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Stocks Extend Slide, Moderna, DraftKings, Deere, Applied Materials In Focus - Five Things To Know

Stock futures extend slide as Treasury yields leap; Moderna slumps after mixed data from flu vaccine trial; DraftKings jumps on narrower Q4 loss, solid revenue outlook; Deere earnings on deck with global equipment demand in focus and Applied Materials sees AI chip demand support firmer Q2 sales.

The Street

I bonded with COVID vaccine sceptics over saunas and Mother Earth rituals – this is what they taught me

I was standing in a forest at night, by a dark lake taking part in a Mother Earth ritual. Shaman drums echoed between the cliffs. The witch leading the ritual suddenly encouraged us to sound like wild animals. The other women seemed to greet this as something predictable and expected.…

The Conversation

Risk of COVID death or hospitalisation 88 per cent lower for those previously infected, study finds

One of the largest studies conducted on COVID immunity finds that previous infections provide protection for as long as vaccination, but experts caution vaccines are still the safer option.

ABC News

Mixed results for Moderna mRNA flu vaccine trial

Washington (AFP) - US biotech company Moderna said Thursday it had mixed results from a large-scale trial of its mRNA flu shot, based on the same technology used in its successful Covid-19 vaccine.

AFP

Read news from The Economist, FT, and more,
with one subscription

Marburg virus, a relative of Ebola with no approved vaccines or treatments, is spreading in West Africa. Here's what you need to know

The risk to the U.S. is low, experts say. But "what happens in Africa can show up in your backyard hospital in less than 24 hours,” Dr. Luis Ostrosky, an infectious diseases specialist at The University of Texas Health Science Center at Houston, tells Fortune.

Fortune

Moderna, Pfizer and BioNTech Covid vaccine patent dispute heads to 2024 trial

US firm Moderna is suing its competitors for alleged patent infringement in relation to their Comirnaty vaccine.

The Independent UK

What happens to COVID vaccines and drugs authorized for emergency use when health emergency ends?

On May 11, the central pillar of the country's pandemic response — the declaration of a national emergency that began March 1, 2020 — will come down. But Americans will continue to have access to the vaccines, drugs and medical devices that were authorized for emergency use against COVID-19, so…

Los Angeles Times

Moderna won’t raise price on COVID vaccine after pressure

Moderna said Wednesday it wouldn’t raise the price of its COVID-19 vaccine after a public outcry.

Tribune News Service

U.S. backs Moderna, says government should face COVID-19 vaccine lawsuit

The U.S. government should face a patent lawsuit over COVID-19 vaccines, not vaccine maker Moderna Inc, the Department of Justice told a Delaware federal court on Tuesday.

Reuters

Adelaide Hills woman who pleaded guilty to vaccine fraud was fearful of COVID-19 jab, court hears

An Adelaide Hills woman was overwhelmed with fear and anxiety about the COVID-19 jab before she paid a vulnerable person to take the dose in her name, a court hears.

ABC News

Study: Unless most people get an annual COVID vaccine, tens of thousands will die in the US each year

Public health experts warned from the beginning of the COVID-19 pandemic that the disease was “not like the flu,” resulting in far more deaths and hospitalizations each year.

The Philadelphia Inquirer

Get all your
news in one place.

100’s of premium titles.
One news app.

Tribune News Service

Do you know who to talk to about your child's routine vaccinations?

According to the Centers for Disease Control and Prevention (CDC), routine vaccinations for kindergarten in the U.S. fell to 93% during the 2021-2022 school year. That's the second year in a row routine vaccination rates decreased. The vaccines help prevent potentially fatal or severe illnesses, including diphtheria, measles, mumps, rubella,…

AAP

CSL grows first-half profit 10pct to $2.6 billion

CSL has beaten first-half earnings expectations thanks to its vaccine business and contributions from its new iron deficiency therapy company.

Axios

Congress braces for first GOP-led investigation into COVID vaccines

It’s a sharp turn from the Democratic-led panel last year.

The Conversation

Advantages and challenges of anti-Covid nasal vaccination: the promises of a French approach

Contrary to the widely shared popular belief, the primary purpose of current vaccines against Covid-19 is solely to protect against serious forms of the disease in order to prevent the risk of hospitalisations and death… and not to block transmission between individuals. To do this, it would be necessary to…

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

The Best Stock to Invest $1,000 in Right Now

Pfizer (PFE) played a pivotal role in developing vaccines and pills that helped the world return to normal from the COVID-19 pandemic. The company reported record revenue and earnings in fiscal 2022. Given the company’s solid growth prospects, it could be wise to invest in the stock right now. Keep…

Dynamite News

New study explores challenges of developing mucosal vaccines for respiratory viruses

Vaccines that provide long-lasting protection against influenza, coronaviruses and respiratory syncytial virus (RSV) are difficult to develop. Read further on Dynamite:

ABC News

Japanese encephalitis virus vaccine eligibility boosted in South Australia as flood clean-up continues

South Australia's Chief Public Health Officer Nicola Spurrier says all residents in the state's flood-hit Riverland and Murraylands regions will now be eligible for the free JEV vaccine.

ABC News

Mpox vaccination encouraged ahead of global LGBTQI+ WorldPride festival in Sydney

Australians heading to Sydney WorldPride who are eligible for mpox (previously monkeypox) vaccination are being encouraged to roll up their sleeves and get a jab ahead of the global LGBTIQ+ festival later this month.

Wales Online

Science says UK needs to rethink stopping Covid boosters for young and healthy people

The offer of third doses to everyone over 16 will be withdrawn after today

Inverse

Can a Universal Flu Vaccine Actually Work? mRNA Technology Is a Budding Solution

How do you make a universal flu vaccine? A microbiologist explains the challenges and how mRNA could offer a promising solution

Daily Mirror

Novak Djokovic seeking “special permission” to compete in US amid vaccine requirements

The Australian Open champion faces being prevented from entering America next month for the Indian Wells Masters and Miami Open due to his Covid-19 vaccination status

1 … 75 76 77 78

People

Novak Djokovic

4,792 stories

Marjorie Taylor Greene

1,925 stories

Bernie Sanders

1,125 stories

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Department of Justice

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.